Mesoporous Silica Nanoparticles-Based Nanoplatforms: Basic Construction, Current State, and Emerging Applications in Anticancer Therapeutics

In recent years, researchers are developing novel nanoparticles for diagnostic applications using imaging techniques and for therapeutic purposes through drug delivery techniques. The unique physical and chemical properties of mesoporous silica nanoparticles (MSNs) make it possible to integrate a variety of commonly used therapeutic and imaging agents to construct a multimodal synergistic anticancer drug delivery system. Herein, recent advances in MSNs synthesis for drug delivery and smart response applications are reviewed. First, synthetic strategies for the fabrication of ordered MSNs, hollow MSNs, core-shell structured MSNs, dendritic MSNs, and biodegradable MSNs are outlined. Then, the recent research progress in designing functional MSN materials with various controlled release mechanisms in anticancer therapy is discussed, and new properties are introduced to suggest the latest design requirements as drug delivery materials. The review also highlights significant achievements in bioimaging using MSNs and their multifunctional counterparts as delivery vehicles. Finally, personal views on key directions for future work in this area are presented.

Automated summary

In recent years, researchers have developed novel nanoparticles for diagnostic applications and therapeutic purposes. This review focuses on the synthesis of mesoporous silica nanoparticles (MSNs) for drug delivery and smart response applications, including the fabrication of ordered, hollow, core-shell structured, dendritic, and biodegradable MSNs. The review also discusses recent research progress in designing functional MSN materials with various controlled release mechanisms in anticancer therapy, as well as their bioimaging capabilities and potential as delivery vehicles.